Combined Sono and Photodynamic Therapy for Prostate Cancer — YRD
  1. Schedule
  2. Poster walkabout
  3. Combined Sono and Photodynamic Therapy for Prostate Cancer

Combined Sono and Photodynamic Therapy for Prostate Cancer (#115)

Donald Murphy 1 2 , Brian Meade 3 , Avni Sali 3
  1. Geelong, Vic
  2. Skills Laboratory, RACS, Melbourne
  3. National Institute of Intergrative Medicine, Vic

Aim

To investigate the role of combined sono and photo-dynamic therapy (SPDT) in the treatment of prostate cancer.

Method

This phase 1 ethics approved trial (00250- NEAF code Au/1/ D3F806) has been established to assess the potential role of combined SPDT across a range of prostate cancer patients, including focal disease and those patients with persisting local cancer after radical treatments.

Advanced photo-chemical agents have been used in this trial with activation by specific sound, laser and light emitting diode (LED) light equipment.

Results 

The safety, dosage and side effects of the sensitizers as well as the spectral range of the two energy modalities used, together with the interim results will be presented.

Conclusion

Sono and photodynamic therapy has been shown to be safe and may prove to have a role in the future treatment of prostate cancer patients.